Canada Markets open in 7 hrs 53 mins

Merck to supply up to 1 mln courses of COVID-19 pill to Canada

Dec 3 (Reuters) - Merck & Co said on Friday it would supply the Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19.

The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting